Has The Market Overpriced Moderna’s Vaccine?
- Tuesday, August 4, 2020, 7:14
- Market
- Add a comment
Moderna stock has jumped by about 4x this year adding over $20 billion in market value, as investors bet that a successful Covid-19 vaccine could generate windfall profits for the clinical-stage biotech company. Is this jump in valuation warranted? We don’t think it is, considering the relatively…
About the Author
admin123 has written 23418 stories on this site.
